亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

張家港保稅區(qū)凱利特化工有限公司  

原料藥,醫(yī)藥中間體,精細化學品

搜索
新聞中心
  • 暫無新聞
產品分類
聯(lián)系方式
  • 聯(lián)系人:姚廣
  • 電話:18252995085
  • QQ:524465307
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 托伐普坦中間體137973-76-3
托伐普坦中間體137973-76-3
單價 面議對比
詢價 暫無
發(fā)貨 江蘇蘇州市付款后3天內
型號 137973-76-3
過期 長期有效
更新 2012-08-30 13:44
 
詳細信息

中文名稱:

7--1-[2-甲基-4-[(2-甲基苯甲酰)氨基]苯甲酰基]-5-氧代-2,3,4,5-四氫-1H-1-苯并氮雜卓

中文別名:

N-[4-[(7--2,3,4,5-四氫-5-氧代-1H-1-苯并氮雜卓-1-)羰基]-3-甲基苯基]-2-甲基苯甲酰胺

英文名稱:  

7-chloro-1-[2-methyl-4-[(2-methylbenzoyl)amino]benzoyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine

英文別名:  

N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide

CAS號: 137973-76-3

含量:≥99.55%

單雜:0.1%

觀:白色固體

途:托伐普坦中間體137973-76-3

©2025 張家港保稅區(qū)凱利特化工有限公司 版權所有   技術支持:化工網(wǎng)   訪問量:14781  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |